Assessment of the Impact of Neocement Inject P® (Beta-Tricalcium Phosphate) on Bone Volume in Alveolar Ridge Preservation After Tooth Extraction

Assessment of Safety and Performance of Neobone®: A Prospective Observational Study in the Field of Dentistry

The goal of this randomized clinical trial is to assess whether β-TCP (Beta-Tricalcium Phosphate) improves alveolar ridge preservation (ARP) in patients who need tooth extraction. The main question it aims to answer is whether using β-TCP for alveolar ridge preservation has a positive effect on bone volume compared with natural healing.

The main questions it aims to answer are:

Does β-TCP improve ridge preservation compared with natural healing?

Researchers will compare β-TCP grafted sockets to natural healing sockets to see if β-TCP better preserves ridge volume.

Participants will:

Have a tooth indicated for extraction.

Be assigned to either β-TCP or natural healing.

Undergo CBCT (Cone Beam Computed Tomography) and intra-oral scanning after extraction and after six months of healing to measure horizontal and vertical resorption and bone density.

Inclusion Criteria:

• 18 years or older
• Acceptance of informed consent
• Type 1 or 2 extraction sockets (Elian et al. 2007)

Exclusion Criteria:

• Presence of active infection or severe inflammation in the intervention zone
• Relevant medical history that contraindicates implant surgery
• Patients with poor oral hygiene (full-mouth plaque score and full-mouth bleeding score >15%) and lack of motivation
• Uncontrolled diabetes (reported levels of glycated haemoglobin exceeding 7%)
• Uncontrolled and /or untreated periodontal disease
• Heavy smokers (more than 10 cigarettes per day)
• Immunosuppression